Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 10;2(12):1287-1288.
doi: 10.1016/j.medj.2021.11.005.

Artemisinin resistance in Africa: How urgent is the threat?

David A Fidock  1   2 , Philip J Rosenthal  3
Affiliations

Artemisinin resistance in Africa: How urgent is the threat?

David A Fidock et al. Med. .

Abstract

Malaria is unrelenting in its impact on sub-Saharan Africa, with an estimated 215 million cases and 384,000 deaths in 2019, mostly in young children. Although devastating, this situation represents a halving in incidence and mortality compared to the early 2000s, associated with continent-wide implementation of effective artemisinin (ART)-based combination therapies (ACTs) and enhanced mosquito vector control measures. Now, however, clinically confirmed ART resistance has emerged in Rwanda and northern Uganda.

PubMed Disclaimer

Conflict of interest statement

DECLARATION OF INTERESTS The authors declare no competing interests.

References

    1. WWARN K13 Genotype-Phenotype Study Group (2019). Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis. BMC Med. 17, 1. - PMC - PubMed
    1. Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, Habimana RM, Rucogoza A, Moriarty LF, Sandford R, et al. (2021). Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect. Dis 21, 1120–1128. - PMC - PubMed
    1. Straimer J, Gandhi P, Renner KC, and Schmitt EK (2021). High prevalence of P. falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine. J. Infect. Dis jiab352. 10.1093/infdis/jiab352. - DOI - PMC - PubMed
    1. Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, Opio W, Emoto S, Anywar DA, Kimura E, et al. (2021). Evidence of artemisinin-resistant malaria in Africa. N. Engl. J. Med 385, 1163–1171. - PubMed
    1. Uwimana A, Legrand E, Stokes BH, Ndikumana JM, Warsame M, Umulisa N, Ngamije D, Munyaneza T, Mazarati JB, Munguti K, et al. (2020). Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat. Med 26, 1602–1608. - PMC - PubMed

Publication types

LinkOut - more resources